Nephropathic cystinosis is an autosomal recessive inborn error of meta
bolism characterized by the lysosomal storage of the disulphide amino
acid cystine. It produces a variety of clinical manifestations includi
ng failure to thrive, the renal Fanconi syndrome, eye findings, and en
d-stage renal disease. A variety of phenotypes are known; however, the
molecular defect underlying any of the forms has not yet been identif
ied. Therapy of cystinosis with cysteamine averts the otherwise inevit
able renal failure, but systemic therapy does not improve the corneal
keratopathy. A number of presentations in this review detail approache
s to gene identification, systemic therapy with cysteamine, measuremen
t of cystine, and pathophysiological effects at the cellular and clini
cal level.